Investor Relations
Posted Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2025
Notice of Resolutions at the 57th Ordinary General Meeting of Shareholders
Posted Company Briefing Presentation for Our Stakeholders
Posted Hemostasis Briefing Presentation
Posted Financial Results for the Fiscal Year Ended March 31, 2024
Posted the 21st Technology Presentation
Posted Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024
